Cargando…

Isoniazid Induces Apoptosis Of Activated CD4(+) T Cells: IMPLICATIONS FOR POST-THERAPY TUBERCULOSIS REACTIVATION AND REINFECTION

Tuberculosis (TB) remains the second highest killer from a single infectious disease worldwide. Current therapy of TB is lengthy and consists of multiple expensive antibiotics, in a strategy referred to as Directly Observed Treatment, Short Course (DOTS). Although this therapy is effective, it has s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tousif, Sultan, Singh, Dhiraj Kumar, Ahmad, Shaheer, Moodley, Prashini, Bhattacharyya, Maitree, Van Kaer, Luc, Das, Gobardhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2014
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215201/ https://www.ncbi.nlm.nih.gov/pubmed/25202011 http://dx.doi.org/10.1074/jbc.C114.598946

Ejemplares similares

Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy
por: Tousif, Sultan, et al.
Publicado: (2017)

A peptide fragment from the human COX3 protein disrupts association of Mycobacterium tuberculosis virulence proteins ESAT-6 and CFP10, inhibits mycobacterial growth and mounts protective immune response
por: Samuchiwal, Sachin Kumar, et al.
Publicado: (2014)

Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

Clofazimine enhances the efficacy of BCG revaccination via stem cell-like memory T cells
por: Ahmad, Shaheer, et al.
Publicado: (2020)

Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis*
por: Rahman, Md. Aejazur, et al.
Publicado: (2015)

Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection
por: Tousif, Sultan, et al.
Publicado: (2011)

A novel peptide interferes with Mycobacterium tuberculosis virulence and survival
por: Samuchiwal, Sachin Kumar, et al.
Publicado: (2014)

Transforming Growth Factor-β Protein Inversely Regulates in Vivo Differentiation of Interleukin-17 (IL-17)-producing CD4(+) and CD8(+) T Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

CD4(+) T Cell-derived Novel Peptide Thp5 Induces Interleukin-4 Production in CD4(+) T Cells to Direct T Helper 2 Cell Differentiation
por: Khan, Mohd Moin, et al.
Publicado: (2012)

Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host Immunity
por: Singh, Yogesh, et al.
Publicado: (2013)

Curcumin Nanoparticles Enhance Mycobacterium bovis BCG Vaccine Efficacy by Modulating Host Immune Responses
por: Ahmad, Shaheer, et al.
Publicado: (2019)

Cellular Architecture of Spinal Granulomas and the Immunological Response in Tuberculosis Patients Coinfected with HIV
por: Bhattacharya, Debapriya, et al.
Publicado: (2017)

Mycobacterium tuberculosis Subverts the TLR-2 - MyD88 Pathway to Facilitate Its Translocation into the Cytosol
por: Rahman, Md. Aejazur, et al.
Publicado: (2014)

Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2020)

Correction: Luteolin-mediated Kv1.3 K(+) channel inhibition augments BCG vaccine efficacy against tuberculosis by promoting central memory T cell responses in mice
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

Reply to Levis and Rendini
por: Singh, Dhiraj Kumar, et al.
Publicado: (2017)

Prostanoid Receptor 2 Signaling Protects T Helper 2 Cells from BALB/c Mice against Activation-induced Cell Death
por: Kaul, Vandana, et al.
Publicado: (2012)

Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
por: Bhattacharya, Debapriya, et al.
Publicado: (2014)

Pivotal roles of CD8(+) T cells restricted by MHC class I–like molecules in autoimmune diseases
por: Das, Gobardhan, et al.
Publicado: (2006)

Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis
por: Dookie, Navisha, et al.
Publicado: (2014)

Molecular genotyping to differentiate endogenous reactivation and exogenous reinfection of recurrent tuberculosis
por: Suzana, Shirly, et al.
Publicado: (2018)

Early Secreted Antigen ESAT-6 of Mycobacterium tuberculosis Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner
por: Chatterjee, Samit, et al.
Publicado: (2011)

Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa
por: Dookie, Navisha, et al.
Publicado: (2016)

Isoniazid Inhibits the Heme-Based Reactivity of Mycobacterium tuberculosis Truncated Hemoglobin N
por: Ascenzi, Paolo, et al.
Publicado: (2013)

Mycobacterium tuberculosis Directs T Helper 2 Cell Differentiation by Inducing Interleukin-1β Production in Dendritic Cells
por: Dwivedi, Ved Prakash, et al.
Publicado: (2012)

Expression of the ARPC4 Subunit of Human Arp2/3 Severely Affects Mycobacterium tuberculosis Growth and Suppresses Immunogenic Response in Murine Macrophages
por: Ghosh, Anamika, et al.
Publicado: (2013)

ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections
por: Chindelevitch, Leonid, et al.
Publicado: (2016)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance
por: Stagg, Helen R., et al.
Publicado: (2019)

The Phytochemical Bergenin Enhances T Helper 1 Responses and Anti-Mycobacterial Immunity by Activating the MAP Kinase Pathway in Macrophages
por: Dwivedi, Ved P., et al.
Publicado: (2017)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

Qa-2–Dependent Selection of Cd8α/α T Cell Receptor α/β(+) Cells in Murine Intestinal Intraepithelial Lymphocytes
por: Das, Gobardhan, et al.
Publicado: (2000)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Strains of Mycobacterium tuberculosis differ in affinity for human osteoblasts and alveolar cells in vitro
por: Sarkar, Shrabanti, et al.
Publicado: (2016)

Qa-2–Dependent Selection of Cd8α/α T Cell Receptor α/β (1) Cells in Murine Intestinal Intraepithelial Lymphocytes
por: Das, Gobardhan, et al.
Publicado: (2001)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_9id7a8jbmro5uf4tlbbqchc48c